贝恩行业分析RetailCo1.pptxVIP

bc;Background Approach Conclusion Implementation Results; ;Achieve top quartile performance market/book value: 2.8x return on equity: 17-18% annual earnings growth: 10-12%;Agenda;Define the characteristics of a successful strategy Develop a range of viable strategic alternatives Assess and prioritise the strategic alternatives Build consensus around the preferred strategy Fully quantify the impact of appropriate action steps Gain final approval Launch implementation;Components of Successful Strategy; ;Fact Base;Agenda;Business Unit Evaluations (1 of 2);Business Unit Evaluations (2 of 2);Business Unit Recommendations;Strategic Alternatives;Revise the mix of businesses in the portfolio allow North to pursue an independent strategy sell France, Spain and Sweden at the right price and time Ensure remaining businesses address the most important strategic issues establish clear strategies for growth businesses (Holland, Luxembourg, Hong Kong, Italy) finalise turnaround plans for businesses which cant be sold at reasonable prices take write-offs as required Consider acquisitions Reduce corporate expenses Add value to the businesses in the portfolio build RD capabilities leverage costs upgrade the organisation;Chain drug industry is consolidating economies of scale in systems investments relationships with third-party payers An independent North generates significantly more shareholder value as it participates in the evolution of the industry North makes minimal use of corporate functions; there is little cost-sharing among North and the other divisions Market timing is attractive Norths value is not being fully recognized in the marketplace;Planned capacity additions will result in industry-wide negative comp store sales through 1998 Consolidation is essential to eliminate excess capacity lowers costs allows comp store sales growth Retail Co is better suited to be a seller than a buyer synergy is equal whether France chooses to acquire or be acquired leading competi